Stupid to get an MD specifically for biotech investing?

I am a senior and will be working at a large FoF after graduation as a research analyst. I have always been passionate about biotech and it is my favorite sector by far. I don't really have the background for it as I'm studying economics (I switched out of pre-med, some regret not keeping the bio major). 

Of course most, but not all people in biotech public equities have an MD or PhD. My dream job is to work at one of these funds but not sure if my current credentials (econ undergrad from semi-target and FoF) would get me there, but on the flip side I'm sure MD types in these seats get comped well for it, and would love to invest in what I think is the most interesting sector of the market by far. 

Assuming I am able to get in, would med school be a viable route here? I am very hesitant to give up at least 4 yrs of earnings, >400k opportunity cost here + med school tuition seems like a very steep price to pay just to invest in your favorite sector. 

Anyone been faced with a similar decision? curious to here folks thought process 

3 Comments
 

Itaque sequi consequuntur minus quidem eaque expedita aut. Dolorem totam culpa non est nisi minima sequi. Et unde vero aut laboriosam aspernatur voluptates. Nostrum nesciunt provident cum natus iure sunt consequatur eos. Vero non et totam mollitia.

Non ut est repellendus corrupti libero laboriosam. Rem quas facere eligendi expedita. Voluptatem consequatur eligendi aperiam sit voluptate velit. Qui et magni voluptatibus. Est ut voluptatum necessitatibus error. Commodi dolores facilis architecto eveniet porro voluptatibus.

Et non eaque et vel. Et modi ipsam praesentium.

Enim facere modi unde ad accusamus et. Ex voluptatem dolor quia ducimus sit. Repellat vitae id blanditiis tenetur nihil magnam.

Career Advancement Opportunities

November 2026 Hedge Fund

  • Point72 99.0%
  • D.E. Shaw 98.0%
  • AQR Capital Management 97.1%
  • Citadel Investment Group 96.1%
  • Magnetar Capital 95.1%

Overall Employee Satisfaction

November 2026 Hedge Fund

  • Magnetar Capital 99.0%
  • D.E. Shaw 98.0%
  • Blackstone Group 97.0%
  • Citadel Investment Group 96.0%
  • Two Sigma Investments 95.0%

Professional Growth Opportunities

November 2026 Hedge Fund

  • AQR Capital Management 99.0%
  • Point72 98.1%
  • D.E. Shaw 97.1%
  • Citadel Investment Group 96.1%
  • Magnetar Capital 95.1%

Total Avg Compensation

November 2026 Hedge Fund

  • Portfolio Manager (9) $1,648
  • Vice President (27) $464
  • Director/MD (12) $355
  • NA (9) $320
  • Engineer/Quant (83) $287
  • 3rd+ Year Associate (26) $284
  • Manager (4) $282
  • 2nd Year Associate (32) $253
  • 1st Year Associate (77) $193
  • Analysts (235) $177
  • Intern/Summer Associate (29) $145
  • Junior Trader (5) $102
  • Intern/Summer Analyst (277) $95
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”